Susan Dexter

Ms. Susan Dexter is a Chief Technical Officer at Sonnet BioTherapeutics, Inc. and an Independent Non-Executive Director at Sartorius Stedim Biotech SA. She is on the Board of Directors at Sartorius Stedim Biotech SA, Virica Biotech, Inc. and Virocell, Inc. Ms. Dexter was previously employed as a Chief Technical Officer by Sonnet BioTherapeutics Holdings, Inc., a Managing Director by Latham BioPharm Group, Inc., a Chief Business Officer by Xcellerex, Inc., a Vice President-Business Development by The Dow Chemical Co.(Delaware), an Associate Director-Business Development by Lonza Biologics Plc, a Vice President-Business & Strategic Development by Collaborative BioAlliance Inc & Collaborative Smithfield Corp, a Director & Chief Marketing Officer by FUJIFILM Diosynth Biotechnologies Texas LLC, and a Professor-Emeritus by University College London.
She also served on the board at BioSense Technologies and City of College Station (Texas).
She received her undergraduate degree from Harvard University and an undergraduate degree from American University.